These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10102976)

  • 1. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
    Jones R; Crouch SL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.
    Jones RH; Baxter G
    Aliment Pharmacol Ther; 1997 Jun; 11(3):541-6. PubMed ID: 9218080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE; Kahrilas PJ; Sontag SJ; Kovacs TO; Huang B; Pencyla JL
    Am J Gastroenterol; 2001 Nov; 96(11):3089-98. PubMed ID: 11721754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
    Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.
    Adachi K; Hashimoto T; Hamamoto N; Hirakawa K; Niigaki M; Miyake T; Taniura H; Ono M; Kaji T; Suetsugu H; Yagi J; Komazawa Y; Mihara T; Katsube T; Fujishiro H; Shizuku T; Hattori S; Yamamoto S; Kinoshita Y
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1392-8. PubMed ID: 14675268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
    Wong WM; Wong BC; Hung WK; Yee YK; Yip AW; Szeto ML; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Lam SK
    Gut; 2002 Oct; 51(4):502-6. PubMed ID: 12235071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
    Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis.
    Richter JE; Kovacs TO; Greski-Rose PA; Huang section sign B; Fisher R
    Aliment Pharmacol Ther; 1999 Jun; 13(6):795-804. PubMed ID: 10383510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
    Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
    Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia.
    van Rensburg C; Berghöfer P; Enns R; Dattani ID; Maritz JF; Gonzalez Carro P; Fischer R; Schwan T
    Curr Med Res Opin; 2008 Jul; 24(7):2009-18. PubMed ID: 18534050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.
    Corazziari ES; Gasbarrini A; D'Alba L; D'Ovidio V; Riggio O; Passaretti S; Annibale B; Cicala M; Repici A; Bassotti G; Ciacci C; Di Sabatino A; Neri M; Bragazzi MC; Ribichini E; Radocchia G; Iovino P; Marazzato M; Schippa S; Badiali D
    Am J Gastroenterol; 2023 Nov; 118(11):2014-2024. PubMed ID: 37307528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid healing of gastric ulcers with lansoprazole.
    Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
    Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.